From: Use of vaginal mesh for pelvic organ prolapse repair: a literature review
| Randomized trials | Non randomized trials | ||||||
---|---|---|---|---|---|---|---|---|
Graft type | All | NAS meshes | Biologic meshes | All | NAS meshes | AS meshes | Mixed meshes | Biologic meshes |
Mesh Exposition | 6.1% | 11% | 0.34% | 7.7% (0–34.1) | 7.9% (0–34.1) | 6.4% (0–12.9) | 7.9% (0–30) | 5.5% (0–16.7) |
45 patients out of 733 in 13 trials(0% to 35.7%) | 44 patients out of 398 in 9 trials (5% to 35.7%) [6, 9–12, 14, 15, 19, 20] | 1 patient out of 298 in 5 trials (0% to 3.6%) [7, 13, 15, 17, 18] | 98 trials n = 10076 | 84 trials n = 8747 | 2 trials n = 173 | 8 trials n = 786 | 4 trials n = 370 | |
De novo urinary incontinence | 6.3% | 7.8% | 1 patient out of 96 in 1 trial [15] | 7% (0–24%) | 6.6% (0%–24%) | 0 | 5.6% | 16.8% |
26 patients out of 415 in 8 trials (0% to 40%) | 25 patients out of 319 in 7 trials (0% to 40%) [6, 9, 11, 14–16, 20] | 26 trials n = 3078 | 24 trials n = 2941 | 1 trialn = 36 | 1 trial n = 101 | |||
De novo Dyspareunia | 5.3% | 6.7% | None out of 35 patients in 1 trial [13] | 9.2% (0–69) | 9.2% (0–69) | 3% | 14.9% (4.5–27) | 4.9% (0.9–10) |
9 patients out of 170 in 4 trials (0% to 27.8%) | 42 trials n = 3444 | 35 trials n = 3008 | 1 trial n = 90 | 3 trials n = 115 | 3 trials n = 231 |